Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q3 2025 Earnings Call Transcript November 4, 2025
Aurinia Pharmaceuticals Inc. beats earnings expectations. Reported EPS is $0.23, expectations were $0.16.
Operator: Good morning. Welcome to the Aurinia Pharmaceuticals Third Quarter 2025 Conference Call. [Operator Instructions] I will now turn the call over to Peter Greenleaf, President and Chief Executive Officer of Aurinia.
Peter Greenleaf: Thank you all for joining us to discuss Aurinia’s third...
